Close

Standpoint Research Downgrades Teva Pharma (TEVA) to Hold

October 2, 2014 11:15 AM EDT
Get Alerts TEVA Hot Sheet
Price: $14.11 -2.22%

Rating Summary:
    12 Buy, 25 Hold, 1 Sell

Rating Trend: = Flat

Today's Overall Ratings:
    Up: 13 | Down: 11 | New: 11
Join SI Premium – FREE

Standpoint Research downgraded Teva Pharma (NYSE: TEVA) from Buy to Hold.

For an analyst ratings summary and ratings history on Teva Pharma click here. For more ratings news on Teva Pharma click here.

Shares of Teva Pharma closed at $52.99 yesterday.



Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

Downgrades

Related Entities

Standpoint Research